验证数据展示
经过测试的应用
| Positive WB detected in | L02 cells, Neuro-2a cells | 
| Positive IHC detected in | human lung cancer tissue, human liver cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 | 
| Positive IF/ICC detected in | L02 cells | 
推荐稀释比
| 应用 | 推荐稀释比 | 
|---|---|
| Western Blot (WB) | WB : 1:200-1:1000 | 
| Immunohistochemistry (IHC) | IHC : 1:20-1:200 | 
| Immunofluorescence (IF)/ICC | IF/ICC : 1:20-1:200 | 
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
产品信息
13053-1-AP targets PFDN2 in WB, IHC, IF/ICC, ELISA applications and shows reactivity with human, mouse samples.
| 经测试应用 | WB, IHC, IF/ICC, ELISA Application Description | 
| 经测试反应性 | human, mouse | 
| 免疫原 | CatNo: Ag3720 Product name: Recombinant human PFDN2 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-154 aa of BC012464 Sequence: MAENSGRAGKSSGSGAGKGAVSAEQVIAGFNRLRQEQRGLASKAAELEMELNEHSLVIDTLKEVDETRKCYRMVGGVLVERTVKEVLPALENNKEQIQKIIETLTQQLQAKGKELNEFREKHNIRLMGEDEKPAAKENSEGAGAKASSAGVLVS种属同源性预测 | 
| 宿主/亚型 | Rabbit / IgG | 
| 抗体类别 | Polyclonal | 
| 产品类型 | Antibody | 
| 全称 | prefoldin subunit 2 | 
| 别名 | PFD2, HSPC231 | 
| 计算分子量 | 154 aa, 17 kDa | 
| 观测分子量 | 17-20 kDa | 
| GenBank蛋白编号 | BC012464 | 
| 基因名称 | PFDN2 | 
| Gene ID (NCBI) | 5202 | 
| RRID | AB_2877905 | 
| 偶联类型 | Unconjugated | 
| 形式 | Liquid | 
| 纯化方式 | Antigen affinity purification | 
| UNIPROT ID | Q9UHV9 | 
| 储存缓冲液 | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. | 
| 储存条件 | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. | 
实验方案
| Product Specific Protocols | |
|---|---|
| IF protocol for PFDN2 antibody 13053-1-AP | Download protocol | 
| IHC protocol for PFDN2 antibody 13053-1-AP | Download protocol | 
| WB protocol for PFDN2 antibody 13053-1-AP | Download protocol | 
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols | 






